Disposable Endoscopes Market worth $2.67 billion by 2030
The report "Disposable Endoscopes Market by Type (GI Endoscopes, Urology Endoscopes, Laryngoscopes), Clinical Usage (Diagnostic, Surgical), Application (Urology, Gastroenterology, ENT Endoscopy), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030", is projected to reach USD 2.67 billion by 2030, growing from USD 0.95 billion in 2025, at a CAGR of 22.9% during the forecast period.
Browse 250 market data Tables and 60 Figures spread through 350 Pages and in-depth TOC on "Disposable Endoscopes Market by Type (GI Endoscopes, Urology Endoscopes, Laryngoscopes), Clinical Usage (Diagnostic, Surgical), Application (Urology, Gastroenterology, ENT Endoscopy), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/disposable-endoscopes-market-14518319.html
The disposable endoscopes market is growing because of rising procedural volumes caused by increasing chronic gastrointestinal and urological conditions and a growing patient preference for minimally invasive diagnostics. The spread of day-care endoscopy centers and the ongoing shift toward outpatient procedures are also boosting demand. Opportunities for key players include developing affordable single-use endoscopes, adopting them more widely in emerging and underdeveloped healthcare markets, and integrating AI-driven analytics and robotic technologies. These innovations allow for real-time diagnostics, enhance procedural accuracy, and support informed clinical decision-making across various care settings.
The urology endoscopes segment accounted for the largest share in 2024
By type, the disposable endoscopes market is segmented into urology endoscopes, bronchoscopes, cystoscopes, laryngoscopes, GI endoscopes, arthroscopes, and other disposable endoscopes. Among these, the urology endoscopes segment held the largest market share in 2024, due to the rising prevalence of chronic kidney and ureteral diseases, along with increasing incidences of prostate disorders. Urology endoscopes, including ureteroscopes, nephroscopes, resectoscopes, and urethroscopes, are widely used for diagnosing and treating these conditions. According to the Centers for Disease Control and Prevention (CDC), as of 2023, more than 1 in 7 U.S. adults—about 35.5 million people—are estimated to have chronic kidney disease (CKD). Additionally, the American Cancer Society projects around 313,780 new cases and 35,770 deaths from prostate cancer in 2025. The increasing procedural volume, combined with infection control benefits and the ease of use of disposable urology endoscopes, drives their dominant market share.
The hospitals segment accounted for the largest share in 2024
By end user, the disposable endoscopes market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users such as diagnostic centers, mobile endoscopy facilities, and office-based endoscopy service providers. Among these, the hospital segment held the largest market share in 2024 due to the high volume of diagnostic and therapeutic procedures performed within hospital settings. Hospitals serve as primary centers for advanced and complex endoscopic interventions across specialties like gastroenterology, urology, and pulmonology. The availability of skilled healthcare professionals, advanced infrastructure, and robust infection control protocols supports the adoption of disposable endoscopes to reduce cross-contamination risks. Additionally, hospitals increasingly prefer single-use endoscopes to avoid the costs and operational challenges of cleaning and reprocessing reusable scopes. The growing patient influx, rising chronic disease burden, and increased awareness of infection prevention further reinforce hospitals’ dominant role in driving disposable endoscope use globally.
North America dominated the global Disposable endoscopes market in 2024
The disposable endoscopes market is divided into five main regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held the largest share of the global disposable endoscopes market. The region's growth is driven by the high prevalence of chronic diseases, an aging population, and rising procedural volumes across various specialties. According to the U.S. Census Bureau, the population aged 65 and older increased by 3.1% from 2023 to 2024, boosting demand for diagnostic and therapeutic procedures. The Centers for Disease Control and Prevention (CDC) reported that over 35.5 million U.S. adults have chronic kidney disease, while the American Cancer Society projects 2,041,910 new cancer cases in 2025, including 313,780 prostate cancer cases. Additionally, more than one million cystoscopy procedures are performed annually in the U.S. The presence of major companies like Ambu A/S and Boston Scientific, along with FDA initiatives promoting infection prevention through single-use endoscopes, further reinforces North America’s market leadership.
Key Players
Some of the prominent players operating in the market include Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Scivita Medical (China), and Innovex Medical Co., Ltd. (China),.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Disposable Endoscopes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
